Results 261 to 270 of about 1,877,160 (342)

Covalent Activation of the C‐type Lectin DC‐SIGN

open access: yesAngewandte Chemie International Edition, EarlyView.
We introduce the first covalent activators of a C‐type lectin. Using orthogonal functional assays, NMR, MS/MS, and computational modeling, we delineate mechanisms from a functional electrophile‐first screen on dendritic cell‐specific intercellular adhesion molecule‐3‐grabbing non‐integrin (DC‐SIGN) that yields two modes: N‐hydroxysuccinimide (NHS ...
Jonathan Lefèbre   +9 more
wiley   +1 more source

Somatic Embryogenesis: A Biotechnological Route in the Production of Recombinant Proteins. [PDF]

open access: yesBioTech (Basel)
Ramírez-Mosqueda MA   +6 more
europepmc   +1 more source

A Multiepitope‐Based Lateral Flow Assay for Leprosy Antibodies

open access: yesAnalysis &Sensing, EarlyView.
An innovative lateral flow assay for leprosy diagnosis is based on gold nanoparticles and synthetic Mycobacterium leprae epitopes conjugated to keyhole limpet hemocyanin protein to enhance antibody detection. This strategy provides a rapid, accurate, and low‐cost approach for resource‐limited settings, enabling the early detection of infection. Leprosy
Cristiane Zocatelli‐Ribeiro   +7 more
wiley   +1 more source

Reprogramming cancer immunity with next-generation combination therapies. [PDF]

open access: yesFront Cell Dev Biol
Kyriakidis NC   +9 more
europepmc   +1 more source

Optimization and Characterization of Aspirin‐ and Ibuprofen‐Loaded Lipid‐Based Nanoparticle Synthesis for Antibacterial Activity and Cytotoxic Effect

open access: yesAsia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Lipid‐based nanoparticles (LNPs) are favored for drug delivery because of their low toxicity, high biocompatibility, ability to self‐assemble into nanoparticles, and ability to enhance drug bioavailability, thereby improving drug release modulation and pharmacokinetics.
Gulizar Caliskan   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy